← Open Payments lookup

NPI 1124211073: Open Payments

NPI 1124211073. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$29 in 2 payments from 2 companies in 2025. Trend: 2023 $202 · 2024 $96 · 2025 $29

Food & beverage: $29
CompanyPaymentsAmount
Novo Nordisk Inc1$15
Astellas Pharma US Inc1$14

Products named: Veozah.